Thromboxane inhibitors attenuate pathological changes in alcoholic liver disease in the rat

Gastroenterology

Volumn 112, Issue 1, 1997, Pages 200-207

  Nanji, A A ^a   Khwaja, S ^a   Rahemtulla, A ^a   Miao, L ^a   Zhao, S ^a   Tahan, S R ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 OXOTHROMBOXANE B2; 2,3 DINORTHROMBOXANE B2; 3 METHYL 2 (3 PYRIDYL) 1 INDOLEOCTANOIC ACID; 6 OXOPROSTAGLANDIN F1 ALPHA; ALANINE AMINOTRANSFERASE; ALCOHOL; BETA ACTIN; IFETROBAN; MESSENGER RNA; THROMBOXANE B2; THROMBOXANE RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL LIVER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; FATTY LIVER; HISTOPATHOLOGY; INTRAGASTRIC DRUG ADMINISTRATION; LIPID PEROXIDATION; LIVER FIBROSIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0031022238     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(97)70236-1     Document Type: Article

References (51)